Skip to main content
Erschienen in: Langenbeck's Archives of Surgery 6/2014

01.08.2014 | Original Article

Reoperation for post-hepatectomy hemorrhage: increased risk of mortality

verfasst von: Chetana Lim, Safi Dokmak, Olivier Farges, Béatrice Aussilhou, Alain Sauvanet, Jacques Belghiti

Erschienen in: Langenbeck's Archives of Surgery | Ausgabe 6/2014

Einloggen, um Zugang zu erhalten

Abstract

Background

Reoperation for post-hepatectomy hemorrhage (PHH) represents an important complication in patients undergoing liver resection. Yet, few studies have reported its presentation and patient outcomes of this event.

Methods

Among the 2,086 patients who underwent elective hepatectomy from 2000 to 2009 in our HPB unit, the perioperative data of 12 (0.6 %) patients who underwent re-laparotomy for PHH were retrospectively analyzed.

Results

The diagnosis of PHH was established in all cases by the presence of blood in the drain. The mean interval time between the end of liver resection and the diagnosis of bleeding and reoperation were 17 h (1–43) and 38 h (1–93), respectively. The causes of bleeding were the hepatic vein branch (n = 4), liver cut surface (n = 3), and a hepatic artery branch (n = 2). In three cases, no bleeding spot was identified. Postoperative death occurred in 3 patients (25 %) between 15 and 18 days after re-laparotomy. These 3 patients were all cirrhotic; 2 underwent early re-laparotomy (≤6 h) and 1 underwent re-laparotomy 24 h after the first recognition of active bleeding.

Conclusion

Reoperation for PHH remains an important morbid event after liver resection. Death in patients with this complication is considerably high. It is diagnosed mainly on the aspect of the abdominal drain, justifying its use in risky patients.
Literatur
1.
Zurück zum Zitat Jamieson GG, Corbel L, Campion JP, Launois B (1992) Major liver resection without a blood transfusion: is it a realistic objective? Surgery 112(1):32–6PubMed Jamieson GG, Corbel L, Campion JP, Launois B (1992) Major liver resection without a blood transfusion: is it a realistic objective? Surgery 112(1):32–6PubMed
2.
Zurück zum Zitat Melendez JA, Arslan V, Fischer ME et al (1998) Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg 187(6):620–5PubMedCrossRef Melendez JA, Arslan V, Fischer ME et al (1998) Perioperative outcomes of major hepatic resections under low central venous pressure anesthesia: blood loss, blood transfusion, and the risk of postoperative renal dysfunction. J Am Coll Surg 187(6):620–5PubMedCrossRef
3.
Zurück zum Zitat Poon RT, Fan ST (2004) Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transpl 10(2 Suppl 1):S39–45PubMedCrossRef Poon RT, Fan ST (2004) Hepatectomy for hepatocellular carcinoma: patient selection and postoperative outcome. Liver Transpl 10(2 Suppl 1):S39–45PubMedCrossRef
4.
Zurück zum Zitat Rahbari NN, Koch M, Zimmermann JB et al (2011) Infrahepatic inferior vena cava clamping for reduction of central venous pressure and blood loss during hepatic resection: a randomized controlled trial. Ann Surg 253(6):1102–10PubMedCrossRef Rahbari NN, Koch M, Zimmermann JB et al (2011) Infrahepatic inferior vena cava clamping for reduction of central venous pressure and blood loss during hepatic resection: a randomized controlled trial. Ann Surg 253(6):1102–10PubMedCrossRef
5.
Zurück zum Zitat Boonstra EA, Molenaar IQ, Porte RJ, de Boer MT (2009) Topical haemostatic agents in liver surgery: do we need them? HPB (Oxford) 11(4):306–10CrossRef Boonstra EA, Molenaar IQ, Porte RJ, de Boer MT (2009) Topical haemostatic agents in liver surgery: do we need them? HPB (Oxford) 11(4):306–10CrossRef
6.
Zurück zum Zitat Figueras J, Llado L, Miro M et al (2007) Application of fibrin glue sealant after hepatectomy does not seem justified: results of a randomized study in 300 patients. Ann Surg 245(4):536–42PubMedCentralPubMedCrossRef Figueras J, Llado L, Miro M et al (2007) Application of fibrin glue sealant after hepatectomy does not seem justified: results of a randomized study in 300 patients. Ann Surg 245(4):536–42PubMedCentralPubMedCrossRef
7.
Zurück zum Zitat Belghiti J, Hiramatsu K, Benoist S et al (2000) Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191(1):38–46PubMedCrossRef Belghiti J, Hiramatsu K, Benoist S et al (2000) Seven hundred forty-seven hepatectomies in the 1990s: an update to evaluate the actual risk of liver resection. J Am Coll Surg 191(1):38–46PubMedCrossRef
8.
Zurück zum Zitat Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–13PubMedCentralPubMedCrossRef Dindo D, Demartines N, Clavien PA (2004) Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 240(2):205–13PubMedCentralPubMedCrossRef
9.
Zurück zum Zitat Balzan S, Belghiti J, Farges O et al (2005) The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 242(6):824-8–828-9CrossRef Balzan S, Belghiti J, Farges O et al (2005) The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy. Ann Surg 242(6):824-8–828-9CrossRef
10.
Zurück zum Zitat Yang T, Li L, Zhong Q et al (2013) Risk factors of hospital mortality after re-laparotomy for post-hepatectomy hemorrhage. World J Surg 37(10):2394–401PubMedCrossRef Yang T, Li L, Zhong Q et al (2013) Risk factors of hospital mortality after re-laparotomy for post-hepatectomy hemorrhage. World J Surg 37(10):2394–401PubMedCrossRef
11.
Zurück zum Zitat Jarnagin WR, Gonen M, Fong Y et al (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236(4):397–406, 406-7PubMedCentralPubMedCrossRef Jarnagin WR, Gonen M, Fong Y et al (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236(4):397–406, 406-7PubMedCentralPubMedCrossRef
12.
13.
Zurück zum Zitat Teh SH, Nagorney DM, Stevens SR et al (2007) Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 132(4):1261–9PubMedCrossRef Teh SH, Nagorney DM, Stevens SR et al (2007) Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology 132(4):1261–9PubMedCrossRef
14.
Zurück zum Zitat Friedman LS (1999) The risk of surgery in patients with liver disease. Hepatology 29(6):1617–23PubMedCrossRef Friedman LS (1999) The risk of surgery in patients with liver disease. Hepatology 29(6):1617–23PubMedCrossRef
15.
Zurück zum Zitat Gelman S (1987) General anesthesia and hepatic circulation. Can J Physiol Pharmacol 65(8):1762–79PubMedCrossRef Gelman S (1987) General anesthesia and hepatic circulation. Can J Physiol Pharmacol 65(8):1762–79PubMedCrossRef
16.
Zurück zum Zitat Frilling A, Stavrou GA, Mischinger HJ et al (2005) Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial. Langenbecks Arch Surg 390(2):114–20PubMedCrossRef Frilling A, Stavrou GA, Mischinger HJ et al (2005) Effectiveness of a new carrier-bound fibrin sealant versus argon beamer as haemostatic agent during liver resection: a randomised prospective trial. Langenbecks Arch Surg 390(2):114–20PubMedCrossRef
17.
Zurück zum Zitat Schwartz M, Madariaga J, Hirose R et al (2004) Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg 139(11):1148–54PubMedCrossRef Schwartz M, Madariaga J, Hirose R et al (2004) Comparison of a new fibrin sealant with standard topical hemostatic agents. Arch Surg 139(11):1148–54PubMedCrossRef
Metadaten
Titel
Reoperation for post-hepatectomy hemorrhage: increased risk of mortality
verfasst von
Chetana Lim
Safi Dokmak
Olivier Farges
Béatrice Aussilhou
Alain Sauvanet
Jacques Belghiti
Publikationsdatum
01.08.2014
Verlag
Springer Berlin Heidelberg
Erschienen in
Langenbeck's Archives of Surgery / Ausgabe 6/2014
Print ISSN: 1435-2443
Elektronische ISSN: 1435-2451
DOI
https://doi.org/10.1007/s00423-014-1189-3

Weitere Artikel der Ausgabe 6/2014

Langenbeck's Archives of Surgery 6/2014 Zur Ausgabe

Update Chirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

S3-Leitlinie „Diagnostik und Therapie des Karpaltunnelsyndroms“

Karpaltunnelsyndrom BDC Leitlinien Webinare
CME: 2 Punkte

Das Karpaltunnelsyndrom ist die häufigste Kompressionsneuropathie peripherer Nerven. Obwohl die Anamnese mit dem nächtlichen Einschlafen der Hand (Brachialgia parästhetica nocturna) sehr typisch ist, ist eine klinisch-neurologische Untersuchung und Elektroneurografie in manchen Fällen auch eine Neurosonografie erforderlich. Im Anfangsstadium sind konservative Maßnahmen (Handgelenksschiene, Ergotherapie) empfehlenswert. Bei nicht Ansprechen der konservativen Therapie oder Auftreten von neurologischen Ausfällen ist eine Dekompression des N. medianus am Karpaltunnel indiziert.

Prof. Dr. med. Gregor Antoniadis
Berufsverband der Deutschen Chirurgie e.V.

S2e-Leitlinie „Distale Radiusfraktur“

Radiusfraktur BDC Leitlinien Webinare
CME: 2 Punkte

Das Webinar beschäftigt sich mit Fragen und Antworten zu Diagnostik und Klassifikation sowie Möglichkeiten des Ausschlusses von Zusatzverletzungen. Die Referenten erläutern, welche Frakturen konservativ behandelt werden können und wie. Das Webinar beantwortet die Frage nach aktuellen operativen Therapiekonzepten: Welcher Zugang, welches Osteosynthesematerial? Auf was muss bei der Nachbehandlung der distalen Radiusfraktur geachtet werden?

PD Dr. med. Oliver Pieske
Dr. med. Benjamin Meyknecht
Berufsverband der Deutschen Chirurgie e.V.

S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“

Appendizitis BDC Leitlinien Webinare
CME: 2 Punkte

Inhalte des Webinars zur S1-Leitlinie „Empfehlungen zur Therapie der akuten Appendizitis bei Erwachsenen“ sind die Darstellung des Projektes und des Erstellungswegs zur S1-Leitlinie, die Erläuterung der klinischen Relevanz der Klassifikation EAES 2015, die wissenschaftliche Begründung der wichtigsten Empfehlungen und die Darstellung stadiengerechter Therapieoptionen.

Dr. med. Mihailo Andric
Berufsverband der Deutschen Chirurgie e.V.